A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the
- Issued Date
- 2020
- Type
- Article
- Publisher
- ANNALS OF HEMATOLOGY
- Language
- 영어
- ISSN
- 0939-5555
- Citation Volume
- 99
- Citation Number
- 6
- Citation Start Page
- 1283
- Citation End Page
- 1291
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.